Skip to content

A clinical study for evaluating safety of excessive consumption -Non-blind, safety verification study taking 5 times dose of test food "ECM-E" in healthy adults.

A clinical study for evaluating safety of excessive consumption -Non-blind, safety verification study taking 5 times dose of test food "ECM-E" in healthy adults. - A clinical study for evaluating safety of excessive consumption -Non-blind, safety verification study taking 5 times dose of test food "ECM-E" in healthy adults.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000024460
Enrollment
20
Registered
2016-11-01
Start date
2016-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Sponsors

Adaptgen Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Target subject must satisfy the following selection criteria. 1) Healthy Japanese aged from 20 to 45 years-old at the time of giving informed consent 2) A person who is not using chronic or seasonal drugs or medical equipment and is not undergoing rehabilitation therapy 3) A person who has freely given informed consent and has fully understood the purpose of the study 4) A person whose BMI is from 18.5 to 30.0 5) When measuring blood pressure twice, a person whose average blood pressure is within a range of followings; Systolic blood pressure: less than or equal to 139mmHg Diastolic blood pressure: less than or equal to 89mmHg 6) A person whose pulse rate is from 40 to 100 per minute 7) A person whose body temperature is from 35.5 to 37.0 degree Celsius 8) A person who can prevent from excessive exercise during the study 9) A person who can basically have 3 meals in a day during the study 10) A person who can conduct contraception by appropriate ways during the study 11) A person who understands and follows rules and requirements during the study 12) A person who is considered totally fit for participating the study by a comprehensive judgement of lead principal investigator and others.

Exclusion criteria

Exclusion criteria: The following exclusion criteria apply to subjects. 1) A person with the disease in gastrointestinal tract, liver, kidney, heart and circulatory system which have an influence on the absorption, distribution, metabolism and excretion of test food 2) A person with a major surgery history in the gastrointestinal tract sites such as gastrectomy, stomach and intestines suture, the intestinal resection (however, polypectomy, the appendectomy are excluded) 3) A person with a history of cerebrovascular disorder (the asymptomatic lacunar infarct is excluded) 4) A person with tattoo which has an influence on the study because of its size or range 5) A person with hypersensitivity or idiosyncrasy, such as food allergy 6) A person who is suspected to have alcohol or drug dependence 7) A person who has participated in other clinical trials within 84 days from giving an informed consent 8) A person who donated 400 ml of blood within 84 days, 200 ml within 28 days, or a blood component (plasma or platelets) within 14 days from giving an informed consent 9) A person who hopes pregnancy or who cannot prevent conception during the study 10) A nursing or pregnant woman 11) A person who is engaged in night duty

Design outcomes

Primary

MeasureTime frame
-Appearance of adverse events -Height, weight and BMI -Body temperature, blood pressure and pulse -12-lead electrocardiogram -General hematology test -Blood biochemistry test -Urinalysis

Countries

Japan

Contacts

Public ContactHiromichi Hayashi

Medeical Fusion Co.,Ltd. Clinical development division

info@m-fusion.co.jp052-745-3300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026